SELLAS Life Sciences (SLS) Receivables - Other (2012 - 2018)

SELLAS Life Sciences (SLS) has 5 years of Receivables - Other data on file, last reported at $6.6 million in Q3 2018.

• Quarterly Receivables - Other rose 1220.0% year-over-year to $6.6 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $6.6 million (up 1220.0% YoY) and the FY2015 annual result came in at $21.7 million, changed N/A from the prior year.
• Receivables - Other climbed to $6.6 million in Q3 2018 per SLS's latest filing, from $500000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $21.7 million in Q4 2015 and bottomed at $500000.0 in Q3 2017.
• The 4-year median for Receivables - Other is $4.1 million (2016), against an average of $7.6 million.
• Peak annual rise in Receivables - Other reached 1220.0% in 2018, while the deepest fall reached 1220.0% in 2018.
• Tracing SLS's Receivables - Other over 4 years: stood at $21.7 million in 2015, then tumbled by 92.17% to $1.7 million in 2016, then sank by 70.59% to $500000.0 in 2017, then surged by 1220.0% to $6.6 million in 2018.
• Per Business Quant, the three latest SLS Receivables - Other figures stand at $6.6 million (Q3 2018), $500000.0 (Q3 2017), and $1.7 million (Q1 2016).

Peer Comparison